Yale New Haven Children’s Hospital developed a testing protocol with specific clinical indications for testing and clear informed consent expectations.
Panelists discuss how healthcare providers can develop comprehensive management protocols for talquetamab-related toxicities by consulting with specialists, gathering patient feedback, and creating ...
Panitumumab, a fully human monoclonal antibody targeting the epidermal growth factor receptor (EGFR), is approved in the United States and Europe for the treatment of refractory metastatic colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results